EW

Edwards Lifesciences Corporation

Healthcare
85.73 -2.11 -2.40% Pre-Market
2026-07-17 • USD

Key Metrics

Market Cap 49.36B
EV 46.39B
Shares Out 575.80M
Revenue (ttm) 6.30B
Net Income 1.10B
Beta —
P/E —
Forward P/E —
EPS (ttm) $1.88
P/S 7.88
P/B 4.81
P/FCF 45.58
P/C 36.55
EV/Sales 7.36
EV/EBITDA 30.77
ROA 8.23%
ROE 10.47%
ROIC 10.1%
Gross Margin 77.87%
Oper. Margin 21.37%
Profit Margin 17.39%
Debt/Eq 0.07
LT Debt/Cap 5.48%
Quick Ratio 3.16
Current Ratio 4.42
Book/sh 17.83
Cash/sh 4.22
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -5.18%
SMA50 -1.35%
SMA200 2.98%
Volume 4,216,014
Avg Volume 5.01M
Rel Volume 0.84
Perf Week -6.60%
Perf Month -1.87%
Perf Quarter 5.27%
Perf Half Y 2.72%
Perf YTD 0.56%
Perf Year 12.08%
Perf 3Y -7.47%
Perf 5Y -19.56%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Edwards Lifesciences Corporation is the leading global structural heart innovation company driven by a passion to improve patient lives. Through breakthrough technologies,…

Name
Edwards Lifesciences Corporation
Industry
Medical Instruments & Supplies
CEO
Bernard Zovighian · Chief Executive Officer
Employees
16,000 as of 2025-12-31
IPO Date
2018-12-18
Phone
(949) 250-2500
Address
One Edwards Way, Irvine, CA 92614
Website
www.edwards.com

Key Executives

Name Title FY Pay
Bernard Zovighian Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.